Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export

Parkinson’s disease (PD) is a progressive neurodegenerative brain disease presenting with a variety of motor and non-motor symptoms, loss of midbrain dopaminergic neurons in the substantia nigra pars compacta and the occurrence of α-synuclein-positive Lewy bodies in surviving neurons. Here, we perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Shaun, Smolders, Stefanie, Van den Haute, Chris, Heeman, Bavo, van Veen, Sarah, Crosiers, David, Beletchi, Igor, Verstraeten, Aline, Gossye, Helena, Gelders, Géraldine, Pals, Philippe, Hamouda, Norin Nabil, Engelborghs, Sebastiaan, Martin, Jean-Jacques, Eggermont, Jan, De Deyn, Peter Paul, Cras, Patrick, Baekelandt, Veerle, Vangheluwe, Peter, Van Broeckhoven, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244618/
https://www.ncbi.nlm.nih.gov/pubmed/32172343
http://dx.doi.org/10.1007/s00401-020-02145-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244618/
https://www.ncbi.nlm.nih.gov/pubmed/32172343
http://dx.doi.org/10.1007/s00401-020-02145-7

Ejemplares similares